Skip to main content
. 2022 Jun 24;5(6):e2218505. doi: 10.1001/jamanetworkopen.2022.18505

Figure. Overall Rate of Reported Myocarditis or Pericarditis Among People Who Completed the 2-Dose Vaccine Series With the Second Dose on or After June 1, 2021.

Figure.

Error bars indicate 95% CIs. BNT162b2, Pfizer-BioNTech Comirnaty; mRNA-1273, Moderna Spikevax.